Relationship between sonographically measured median nerve cross-sectional area and presence of peripheral neuropathy in diabetic subjects

Table 1 Demographic, anthropometric and clinical characteristics of the study subjects n (%)

Variables	DM, n = 85	HC, n = 85	P-value
Age (yr)
mean ± SD1	61.7 ± 11.1	60.9 ± 10.3	0.620
< 50 yr	11 (12.9)	11 (12.9)	0.965
50-59 yr	25 (29.4)	27 (31.8)
60-69 yr	22 (25.9)	23 (27.1)
≥ 70 yr	27 (31.8)	24 (28.2)
Gender
Male	44 (51.8)	44 (51.8)	1.000
Female	41 (48.2)	41 (48.2)
Height (m)1	1.66 ± 0.08	1.65 ± 0.08	0.473
Weight (Kg)1	71.3 ± 13.6	65.4 ± 11.5	0.003
BMI (Kg/m2)1
mean ± SD1	26.0 ± 5.3	24.1 ± 4.3	0.010
Underweight	3 (3.5)	4 (4.7)	0.072
Normal BMI	35 (41.2)	51 (60.0)
Overweight	31 (36.5)	21 (24.7)
Obese	16 (18.8)	9 (10.6)
Systolic BP (mmHg)1	129.8 ± 20.7	131.9 ± 24.3	0.557
Diastolic BP (mmHg)1	84.2 ± 11.5	82.8 ± 13.1	0.404
Total cholesterol (mmHg)1	4.90	4.78	0.622
FBG (mmol/L)1	7.00 ± 2.16	5.15 ± 0.06	0.001
HbA1C in % (mean ± SD)	8.69 ± 2.46	-	-
Duration of DM in months median (range)	48.0 (0.3-312)	-	-
Peripheral neuropathy	51 (60)	-	-

¹P values < 0.05 are significant. BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; DM: Diabetes mellitus; FBG: Fasting blood glucose; HbA1c: Glycated haemoglobin.